Lv5
1000 积分 2024-08-13 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
11天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
11天前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
11天前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
15天前
已完结
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration
1个月前
已完结
Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
2个月前
已完结
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2个月前
已完结
The regulation of IL-10 production by immune cells
2个月前
已完结
Population Pharmacokinetics of Xeligekimab: An Anti‐IL‐17A Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis
2个月前
已完结
Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells
3个月前
已完结
皖公网安备34019202002308
